Transcription Independent Stimulation of Telomerase Enzymatic Activity by HTLV-I Tax Through Stimulation of IKK.

ATL HBZ HTLV-1 IKK Tax Telomerase hTERT leukemia

Journal

Journal of cancer sciences
ISSN: 2377-9292
Titre abrégé: J Cancer Sci
Pays: United States
ID NLM: 101673154

Informations de publication

Date de publication:
Nov 2021
Historique:
entrez: 23 12 2021
pubmed: 24 12 2021
medline: 24 12 2021
Statut: ppublish

Résumé

The persistence and spreading of HTLV-I infected cells relies upon their clonal expansion through cellular replication. The development of adult T cell leukemia (ATLL) occurs decades following primary infection by HTLV-I. Moreover, identical provirus integration sites have been found in samples recovered several years apart from infected individuals. These observations suggest that infected cells persist in the host for an extended period of time. To endure long term proliferation, HTLV-I pre-leukemic cells must acquire critical oncogenic events, two of which are the bypassing of apoptosis and replicative senescence. In the early stages of disease, interleukin-2 (IL-2)/IL-2R signaling likely plays a major role in combination with activation of anti-apoptotic pathways. Avoidance of replicative senescence in HTLV-I infected cells is achieved through reactivation of human telomerase (hTERT). We have previously shown that HTLV-I viral Tax transcriptionally activates the hTERT promoter. In this study we demonstrate that Tax can stimulate hTERT enzymatic activity independently of its transcriptional effects. We further show that this occurs through Tax-mediated NF-KB activating functions. Our results suggest that in ATLL cells acquire Tax-transcriptional and post-transcriptional events to elevate telomerase activity.

Identifiants

pubmed: 34938859
doi: 10.13188/2377-9292.1000024
pmc: PMC8691565
mid: NIHMS1754982
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : R01 CA201309
Pays : United States

Références

J Biol Chem. 1998 Aug 14;273(33):21132-6
pubmed: 9694868
Curr Biol. 2003 Sep 2;13(17):1549-56
pubmed: 12956959
Clin Cancer Res. 2014 Oct 15;20(20):5217-25
pubmed: 25320371
Science. 1995 Jul 7;269(5220):79-81
pubmed: 7604283
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14950-5
pubmed: 9843996
J Biol Chem. 2005 Jun 24;280(25):23748-57
pubmed: 15833743
Braz J Med Biol Res. 2009 Aug;42(8):761-4
pubmed: 19578703
J Clin Invest. 2013 Oct;123(10):4489-501
pubmed: 24091330
Genes Dev. 2005 Sep 15;19(18):2100-10
pubmed: 16166375
Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):E1269-E1278
pubmed: 29358408
Nat Rev Cancer. 2008 Jun;8(6):450-8
pubmed: 18500246
Blood. 2015 Dec 10;126(24):2570-7
pubmed: 26361794
Cancer Lett. 2012 Oct 28;323(2):223-31
pubmed: 22554713
Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):720-5
pubmed: 16407133
EMBO Rep. 2007 May;8(5):497-503
pubmed: 17396137
Oncogene. 2013 Sep 5;32(36):4222-30
pubmed: 23045287
Genes (Basel). 2020 Mar 13;11(3):
pubmed: 32183119
J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S92-9
pubmed: 8797710
Retrovirology. 2005 Oct 22;2:64
pubmed: 16242045
Int J Cancer. 2004 Apr 20;109(4):559-67
pubmed: 14991578
EMBO J. 1994 Feb 1;13(3):511-21
pubmed: 8313896
Blood. 2008 Oct 1;112(7):2946-55
pubmed: 18511807
J Biol Chem. 2003 Jan 17;278(3):1487-93
pubmed: 12419799
Int J Cancer. 2009 Dec 15;125(12):2863-70
pubmed: 19609947
Leuk Res. 1999 Mar;23(3):311-6
pubmed: 10071087
J Virol. 1998 Nov;72(11):8852-60
pubmed: 9765430
Blood. 2006 Aug 1;108(3):1021-9
pubmed: 16569765
J Virol. 2006 May;80(9):4227-41
pubmed: 16611882
Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5147-52
pubmed: 10220433
IUBMB Life. 2005 Feb;57(2):83-91
pubmed: 16036567
Protein Cell. 2010 Jan;1(1):22-32
pubmed: 21203995
Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415-9
pubmed: 6261256
J Natl Cancer Inst. 2008 Jan 16;100(2):98-108
pubmed: 18182620
Blood. 2013 Jan 31;121(5):791-800
pubmed: 23104922
Retrovirology. 2009 Feb 19;6:19
pubmed: 19228429
J Oncol. 2015;2015:183590
pubmed: 26170835
Blood. 2004 Oct 15;104(8):2523-31
pubmed: 15226182
Microbiol Mol Biol Rev. 2002 Sep;66(3):407-25, table of contents
pubmed: 12208997
Cell. 2001 Aug 10;106(3):275-86
pubmed: 11509177
Blood. 2010 Mar 25;115(12):2441-8
pubmed: 20093405
Front Biosci. 2008 Jan 01;13:2075-90
pubmed: 17981693
Int J Cancer Oncol. 2015 Jun 2;2(2):
pubmed: 26430700
Blood. 2010 Aug 26;116(8):1211-9
pubmed: 20448111
Recent Results Cancer Res. 2015;200:61-79
pubmed: 26376872
Genes Dev. 1990 Nov;4(11):1875-85
pubmed: 2276622

Auteurs

M Bellon (M)

Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, USA.

Y Yuan (Y)

Department of Pharmacology, Baylor College of Medicine, USA.

C Nicot (C)

Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, USA.

Classifications MeSH